Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Neuroimage Clin ; 24: 102020, 2019.
Article in English | MEDLINE | ID: mdl-31734534

ABSTRACT

Treatment with interferon (IFN) has been associated with depressive side effects. Previous neuroimaging studies have provided information about changes in brain activation patterns in patients under treatment with IFN-alpha, but the effect of other IFNs, or the role of the underlying disease, has yet to be clarified. In the present fMRI study, we looked at brain changes after 8 days of IFN-beta treatment in N = =17 healthy volunteers, thus avoiding the possible confound of the effects of underlying pathology in studies of IFN-treated patients with neurological or other medical disorders. We followed a symptom dimensional approach by simultaneously investigating two distinct symptom domains of depressiveness: negative affect (amygdala) and appetitive motivation (ventral striatum). In these early phases of IFN treatment we detected a selective change in neural substrates of appetitive motivation, consistent with the predominant symptomatic change recorded in psychopathology ratings. In contrast, the fMRI phenotype of negative affect, which is known to characterize disorders of affect involving anxiety and depressiveness as well as individual vulnerability to depression, was unchanged after treatment. These findings suggest that IFN may induce an affective syndrome through a mechanism involving down-regulation of appetitive motivation.


Subject(s)
Affect , Amygdala , Anxiety , Depression , Immunologic Factors/pharmacology , Interferon-beta/pharmacology , Motivation , Reward , Ventral Striatum , Adolescent , Adult , Affect/drug effects , Affect/physiology , Aged , Amygdala/diagnostic imaging , Amygdala/drug effects , Amygdala/physiology , Anxiety/chemically induced , Anxiety/diagnostic imaging , Anxiety/physiopathology , Depression/chemically induced , Depression/diagnostic imaging , Depression/physiopathology , Facial Expression , Facial Recognition/drug effects , Facial Recognition/physiology , Female , Humans , Immunologic Factors/adverse effects , Interferon-beta/adverse effects , Magnetic Resonance Imaging , Male , Middle Aged , Motivation/drug effects , Motivation/physiology , Ventral Striatum/diagnostic imaging , Ventral Striatum/drug effects , Ventral Striatum/physiology , Young Adult
2.
PLoS One ; 13(6): e0198244, 2018.
Article in English | MEDLINE | ID: mdl-29864139

ABSTRACT

Functional imaging studies of affective disorders have demonstrated abnormal activity in the amygdala in response to emotionally salient stimuli. Since in other studies this response has been shown to habituate during the scanning session, it is not clear if it may be of use in monitoring disease progression or remission, or in monitoring the effects of therapy, as habituation may confound normalisation of response. We investigated here amygdala activation in healthy participants exposed to displays of emotional facial expressions in a sample of N = 31 individuals assessed twice in an interval of three weeks. At this interval no habituation could be detected, suggesting the validity of this imaging assay in repeated assessments of amygdalar reactivity. However, the fusiform gyrus and the inferior frontal lobes showed decreases in activations that may be related to the role of these areas in encoding visual and emotional aspects of the stimuli.


Subject(s)
Amygdala , Emotions/physiology , Face , Magnetic Resonance Imaging , Visual Perception/physiology , Adult , Amygdala/diagnostic imaging , Amygdala/physiology , Female , Humans , Male
SELECTION OF CITATIONS
SEARCH DETAIL